Novavax Inc. advanced stock charts by Barron's. View NVAX historical stock data and compare to other stocks, and exchanges.
Under the non-exclusive agreement, Pfizer will utilize Novavax’s Matrix-M adjuvant in products across two disease areas, with Novavax receiving a $30 million upfront payment. Additionally, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results